Search

Your search keyword '"Lequoy, Marie"' showing total 124 results

Search Constraints

Start Over You searched for: Author "Lequoy, Marie" Remove constraint Author: "Lequoy, Marie"
124 results on '"Lequoy, Marie"'

Search Results

1. Patient and physician expectations regarding disease and treatment of advanced HCC: The prospective PERCEPTION1 study

3. Deep learning-based phenotyping reclassifies combined hepatocellular-cholangiocarcinoma

4. Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab–bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study

5. Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area: What's new 12 months later?

6. THU-494 Selective internal radiation therapy for unresectable hepatocellular carcinoma in a tertiary center in France, update and final analysis

7. FRI-456 Characterization of the intratumoral immune microenvironment of hepatocellular carcinoma before selective intrahepatic radiation therapy (SIRT) and study of its prognostic value on response to treatment

8. THU-458 No correlation between MASLD and poor outcome of Atezolizumab-Bevacizumab therapy in patients with advanced HCC

9. THU-503 Hepatocellular carcinoma in metabolic dysfunction-associated steatotic liver disease (MASLD): multicenter study comparing patients with or without underlying cirrhosis

10. OS-077 Added value of a combination of positron emission tomography with 18F-FDG and 18 F-Fluorocholine for staging optimization and treatment modification in patients with hepatocellular carcinoma: the prospective multicentric PET HCC01 study

11. Nestin as a diagnostic and prognostic marker for combined hepatocellular-cholangiocarcinoma

13. Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area

14. Selective internal radiation therapy for unresectable HCC: The SIRT downstaging study.

15. Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab–bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study

16. Hepatocellular Carcinomas With Mutational Activation of Beta-Catenin Require Choline and Can Be Detected by Positron Emission Tomography

17. No correlation between MASLD and poor outcome of Atezolizumab‐Bevacizumab therapy in patients with advanced HCC.

18. Deep learning predicts sensitivity to atezolizumab-bevacizumab from digital slides of hepatocellular carcinoma

19. Epidemiology and characteristics of hepatocellular carcinoma in France: results of the first 2000 patients in real-life situations from the French prospective chief cohort

20. Beyond atezolizumab plus bevacizumab in patients with advanced hepatocellular carcinoma: overall efficacy and safety of tyrosine kinase inhibitors in a real-world setting

21. Systemic treatments with tyrosine kinase inhibitors and platinum-based chemotherapy in patients with unresectable or metastatic hepato-cholangiocarcinoma

22. Response to systemic treatments in advanced fibrolamellar carcinoma: A French multicenter retrospective cohort of the AGEO.

24. Systemic Treatments with Tyrosine Kinase Inhibitor and Platinum-Based Chemotherapy in Patients with Unresectable or Metastatic Hepatocholangiocarcinoma.

26. Systemic Treatments with Tyrosine Kinase Inhibitor and Platinum-Based Chemotherapy in Patients with Unresectable or Metastatic Hepatocholangiocarcinoma

28. Quays and other Roman port works in Rouen/Rotomagus (Seine-Maritime)

29. OS-081 - Epidemiology and characteristics of hepatocellular carcinoma in France: results of the first 2000 patients in real-life situations from the French prospective chief cohort

30. LBO-04 - Deep learning predicts sensitivity to atezolizumab-bevacizumab from digital slides of hepatocellular carcinoma

32. Drastic decrease of urgent endoscopies outside regular working hours during the Covid-19 pandemic in the paris area

35. Insulin receptor isoform A favors tumor progression in human hepatocellular carcinoma by increasing stem/progenitor cell features

38. Somatostatin receptors in resected hepatocellular carcinoma: status and correlation with markers of poor prognosis

39. Erratum to: Heregulin-1ß and HER3 in hepatocellular carcinoma: status and regulation by insulin

40. Heregulin-1ß and HER3 in hepatocellular carcinoma: status and regulation by insulin

42. Rouen – Hôpital Charles Nicolle

43. Rouen (76/2). Carte Archéologique de la Gaule

44. Lactate and Venoarterial Carbon Dioxide Difference/Arterial-Venous Oxygen Difference Ratio, but Not Central Venous Oxygen Saturation, Predict Increase in Oxygen Consumption in Fluid Responders*

48. Les amphores Gauloise 12 de Normandie. Le matériel de la nécropole de Vatteville-la-Rue

Catalog

Books, media, physical & digital resources